Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL4257986

COc1ccc([S+](c2ccccc2)c2ccccc2)c2ccccc12.O=S(=O)([O-])C(F)(F)F

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.36
ACHE P22303 2/20 0.36
EP300 Q09472 1/20 0.36
KAT8 Q9H7Z6 1/20 0.36
CDC25B P30305 2/20 0.35
KMT2A Q03164 1/20 0.35
ALDH1A1 P00352 1/20 0.35
FABP4 P15090 4/20 0.35
NPC1 O15118 1/20 0.34
SLC2A1 P11166 1/20 0.34
IMPDH2 P12268 1/20 0.34
IMPDH1 P20839 1/20 0.34
GPR3 P46089 1/20 0.34
PLK1 P53350 1/20 0.34
KEAP1 Q14145 1/20 0.34
NFE2L2 Q16236 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2742272 0.84 IDO1 (0.48) IDO1EP300KAT8CDC25BKMT2A
Trifluoromethanesulfonic Acid SCHEMBL1809323 0.83 ACHE (0.39) ACHEKMT2AGPR3
Trifluoromethanesulfonic Acid SCHEMBL29378393 0.79 ACLY (0.39) KMT2AALDH1A1FABP4SLC2A1
Trifluoromethanesulfonic Acid SCHEMBL547976 0.76 GPR3 (0.38) ACHEKMT2AALDH1A1GPR3KEAP1
Trifluoromethanesulfonic Acid SCHEMBL29402880 0.76 GPR3 (0.38) ACHEKMT2AALDH1A1GPR3KEAP1
SCHEMBL8636736 0.75 IDO1 (0.46) IDO1EP300KAT8CDC25BALDH1A1
Trifluoromethanesulfonic Acid SCHEMBL7863367 0.75 HPRT1 (0.38) KMT2AALDH1A1GPR3
Trifluoromethanesulfonic Acid SCHEMBL3143626 0.75 KCNH2 (0.46) ACHEKMT2AALDH1A1GPR3KEAP1
Trifluoromethanesulfonic Acid SCHEMBL36492 0.75 KCNH2 (0.46) ACHEKMT2AALDH1A1GPR3KEAP1
Trifluoromethanesulfonic Acid SCHEMBL31155703 0.74 GPR3 (0.50) ACHEALDH1A1GPR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090023095-A1 NOVEL COMPOUND, MANUFACTURING METHOD THEREOF, ACID GENERATOR, RESIST COMPOSITION AND METHOD OF FORMING A RESIST PATTERN TOKYO OHKA KOGYO CO., LTD. (JP) 2009-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090023095-A1 NOVEL COMPOUND, MANUFACTURING METHOD THEREOF, ACID GENERATOR, RESIST COMPOSITION AND METHOD OF FORMING A RESIST PATTERN C1R, CYP1B1, C1S IDO1 2375/4885ACHE 4766/4885EP300 4371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.